Answers are grounded in this paper and cite their sources.
Case report reveals rhabdomyolysis and acute renal failure post rosuvastatin increase in a 76-year-old woman, indicating risks of dosage changes.
Rhabdomyolysis is a condition characterized by muscle necrosis and can range from asymptomatic elevation of serum muscle enzymes to life-threatening cases associated with extremely elevated enzyme levels, electrolyte imbalances, and acute renal failure (ARF). Here, we present the case of a 76-year-old woman who developed rhabdomyolysis and ARF secondary to an increase in her rosuvastatin from 10 to 40 mg. In this report, we present a case of a 76-year-old woman who presented with decreased appetite and reduced urine output, presumed to be due to a recent increase in her rosuvastatin dosage leading to rhabdomyolysis.
No takes yet. Share an insight, caveat, or question.
Mohammad et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: